Increased Funding Is Making At-Home Hospital Care A Reality
Studies have indicated that at-home hospital services have lower mortality rates and costs.
- CMS's Hospital at Home waiver has been used by over 200 health systems across 35 states since its 2020 launch.
- Johns Hopkins studies report 30–40% lower readmission rates and up to 25% lower costs for at-home acute care compared to inpatient stays.
- Private insurers UnitedHealthcare and Aetna now cover hospital-at-home services for conditions like pneumonia and congestive heart failure.
- Venture capital funding for hospital-at-home technology startups exceeded $1.2 billion in 2025 alone.
- The model reduces mortality risk by 20–30%, according to a 2024 meta-analysis in the Journal of the American Medical Association.
Frequently Asked Questions
At-home hospital care provides acute-level medical treatment in a patient's home instead of a traditional hospital ward. Patients receive daily visits from nurses and physicians, plus 24/7 remote monitoring, for conditions like pneumonia, heart failure, and COPD.
Yes. Studies from Johns Hopkins and the Journal of the American Medical Association show at-home acute care reduces mortality risk by 20–30% and readmission rates by 30–40% compared to inpatient stays. Strict patient selection and monitoring protocols ensure safety.
Medicare's Hospital at Home waiver covers eligible patients in participating hospitals. Many private insurers like UnitedHealthcare and Aetna also now include hospital-at-home benefits. Coverage varies by plan and condition.
By avoiding overhead of hospital infrastructure, reducing lengths of stay, and preventing hospital-acquired infections. Studies show cost savings of 20–25% per episode compared to traditional inpatient care.
Common conditions include pneumonia, congestive heart failure, chronic obstructive pulmonary disease (COPD), cellulitis, and urinary tract infections. Patients must meet clinical criteria for low-to-moderate acuity.
Topics
Original source
www.forbes.com
Discussion
Join the discussion
Sign in to post a comment or reply.
No comments yet. Be the first to share your thoughts!